These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36154703)

  • 1. Medical and Surgical Treatment of Obesity.
    Reid TJ; Korner J
    Med Clin North Am; 2022 Sep; 106(5):837-852. PubMed ID: 36154703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapies: Anti-Obesity Medications and Endoscopic Bariatric Procedures.
    White ME; Kushnir V
    Gastrointest Endosc Clin N Am; 2024 Oct; 34(4):743-756. PubMed ID: 39277302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating the Chronic Disease of Obesity.
    Gossmann M; Butsch WS; Jastreboff AM
    Med Clin North Am; 2021 Nov; 105(6):983-1016. PubMed ID: 34688422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to obesity management.
    Sweeting AN; Caterson ID
    Intern Med J; 2017 Jul; 47(7):734-739. PubMed ID: 28677316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best Practices in the Management of Overweight and Obesity.
    Tchang BG; Saunders KH; Igel LI
    Med Clin North Am; 2021 Jan; 105(1):149-174. PubMed ID: 33246516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of Advances in Anti-obesity Pharmacotherapy: Implications for a Multimodal Treatment Approach with Metabolic Surgery.
    C Sudlow A; W le Roux C; J Pournaras D
    Obes Surg; 2019 Dec; 29(12):4095-4104. PubMed ID: 31650405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamentals of cardiometabolic risk factor reduction: achieving and maintaining weight loss with pharmacotherapy or bariatric surgery.
    Fabbrini E; Klein S
    Clin Cornerstone; 2008; 9(1):41-8; discussion 49-51. PubMed ID: 19046739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity: Lifestyle management, bariatric surgery, drugs, and the therapeutic exploitation of gut hormones.
    Behary P; Cegla J; Tan TM; Bloom SR
    Postgrad Med; 2015 Jun; 127(5):494-502. PubMed ID: 26040552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacotherapy of obesity-Competition to bariatric surgery or a meaningful supplement?].
    Mazaheri T; Ansari S; Nallagonda M; Kollmann L; Nickel F; Seyfried F; Miras AD
    Chirurgie (Heidelb); 2023 Jun; 94(6):497-505. PubMed ID: 36918431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management.
    Ghusn W; Loftus EV; Johnson AM
    Curr Opin Gastroenterol; 2024 Jul; 40(4):268-275. PubMed ID: 38662340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing insurance-related barriers to novel antiobesity medications: Lessons to be learned from bariatric surgery.
    Gasoyan H; Sarwer DB
    Obesity (Silver Spring); 2022 Dec; 30(12):2338-2339. PubMed ID: 36190393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.
    Tziomalos K; Dimitroula HV; Katsiki N; Savopoulos C; Hatzitolios AI
    Mediators Inflamm; 2010; 2010():364957. PubMed ID: 20224654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress and novel perspectives on obesity pharmacotherapy].
    Faria AM; Mancini MC; Melo ME; Cercato C; Halpern A
    Arq Bras Endocrinol Metabol; 2010 Aug; 54(6):516-29. PubMed ID: 20857056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effective Use of Anti-obesity Medications.
    Schmitz SH; Aronne LJ
    Gastroenterol Clin North Am; 2023 Dec; 52(4):661-680. PubMed ID: 37919019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of adjuvant weight loss medication after bariatric surgery.
    Nor Hanipah Z; Nasr EC; Bucak E; Schauer PR; Aminian A; Brethauer SA; Cetin D
    Surg Obes Relat Dis; 2018 Jan; 14(1):93-98. PubMed ID: 29287757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term pharmacotherapy of obesity in patients that have undergone bariatric surgery: pharmacological prevention and management of body weight regain.
    Gutt S; Schraier S; González Bagnes MF; Yu M; González CD; Di Girolamo G
    Expert Opin Pharmacother; 2019 Jun; 20(8):939-947. PubMed ID: 30882259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical and surgical management of obesity and diabetes: what's new?
    Ammori BJ; Skarulis MC; Soran H; Syed AA; Eledrisi M; Malik RA
    Diabet Med; 2020 Feb; 37(2):203-210. PubMed ID: 31850536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future Therapies in Obesity.
    Pickett-Blakely O; Newberry C
    Gastroenterol Clin North Am; 2016 Dec; 45(4):705-714. PubMed ID: 27837783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Fight Against Obesity Escalates: New Drugs on the Horizon and Metabolic Implications.
    Tsilingiris D; Liatis S; Dalamaga M; Kokkinos A
    Curr Obes Rep; 2020 Jun; 9(2):136-149. PubMed ID: 32388792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.